Nexus obtains FDA OK for methylene blue injectionMethylene blue injection is an oxidation-reduction agent that offers treatment of acquired methemoglobinemia. Aurobindo Pharma inks product development deal with global pharma companyThe agreement is for the development and commercialization of specific products across the respiratory therapeutic category. Dr. Reddy’s, Senores Pharmaceuticals launch generic Stromectol Generic Stromectol is an antiparasitic medicine used to treat certain infections. Lupin receives nod for generic Adderall XR, launches generic Bumex Generic Adderall XR capsules are indicated for the treatment of ADHD in adults and pediatric patients 6 years and older. Amneal obtains FDA OK for generic Byetta, resubmits DHE NDA Exenatide is a GLP-1 agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus. Avenacy debuts generic Precedex Dexmedetomidine injection is an alpha2-adrenergic receptor agonist. Elite receives FDA OK for generic Vyvanse Generic Vyvanse is indicated for the treatment of Attention Deficit Hyperactivity Disorder. Alembic receives FDA nod for generic Corlanor Ivabradine is indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction. Camber releases generic Xeloda Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers. Hims & Hers Health plans to launch generic of Novo Nordisk's Victoza Liraglutide, used to treat Type 2 diabetes, belongs to the first generation of GLP-1 agonists. First Previous 13 14 15 16 17 Next Last